Advertisement

Epidemiology of Migraine in Men and Women

  • Kjersti Grøtta VetvikEmail author
Chapter
Part of the Headache book series (HEAD)

Abstract

Migraine is a primary headache disorder that globally affects about 14% of the population. The prevalence is similar among boys and girls before puberty. At all ages following adolescence, migraine is two to three times more prevalent in women with the maximum sex difference between ages 30 and 45 years. Age at onset and peak incidence rate occur earlier in men than in women. The remission rate from childhood to young adulthood is greater in men than women, but this difference seems to disappear among middle-aged migraineurs. Migraine is ranked as the second and third leading cause of years lived with disability among women and men under 50 years of age and is estimated to cost the European society more than 27 billion euros annually. Women report longer duration of attacks and a greater migraine-related disability, while men are more likely to experience longer periods of remission.

Keywords

Migraine Sex Gender Epidemiology Prevalence Incidence Men Women Burden 

References

  1. 1.
    Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.CrossRefGoogle Scholar
  2. 2.
    Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97:553–622.CrossRefGoogle Scholar
  3. 3.
    Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992;12:221–8. discussion 186.CrossRefGoogle Scholar
  4. 4.
    Radtke A, Neuhauser H. Prevalence and burden of headache and migraine in Germany. Headache. 2009;49:79–89.CrossRefGoogle Scholar
  5. 5.
    Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995;24(3):612–8.CrossRefGoogle Scholar
  6. 6.
    Charles AC, Baca SM. Cortical spreading depression and migraine. Nat Rev Neurol. 2013;9:637–44.CrossRefGoogle Scholar
  7. 7.
    Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia. 1992;12:238–43. discussion 186.CrossRefGoogle Scholar
  8. 8.
    Milovanovic M, Jarebinski M, Martinovic Z. Prevalence of primary headaches in children from Belgrade, Serbia. Eur J Paediatr Neurol. 2007;11:136–41.CrossRefGoogle Scholar
  9. 9.
    Isik U, Ersu RH, Ay P, et al. Prevalence of headache and its association with sleep disorders in children. Pediatr Neurol. 2007;36:146–51.CrossRefGoogle Scholar
  10. 10.
    Stovner LJ, Zwart JA, Hagen K, et al. Epidemiology of headache in Europe. Eur J Neurol. 2006;13:333–45.CrossRefGoogle Scholar
  11. 11.
    Bille B. A 40-year follow-up of school children with migraine. Cephalalgia. 1997;17:488–91. discussion 87.CrossRefGoogle Scholar
  12. 12.
    Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64–9.CrossRefGoogle Scholar
  13. 13.
    Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.CrossRefGoogle Scholar
  14. 14.
    Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.CrossRefGoogle Scholar
  15. 15.
    Buse DC, Loder EW, Gorman JA, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013;53:1278–99.CrossRefGoogle Scholar
  16. 16.
    Linde M, Stovner LJ, Zwart JA, et al. Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia. 2011;31:585–96.CrossRefGoogle Scholar
  17. 17.
    Stewart WF, Wood C, Reed ML, et al. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008;28:1170–8.CrossRefGoogle Scholar
  18. 18.
    Institute for Health Metrics and Evaluation (IHME). GBD Compare. Seattle, WA: IHME, University of Washington, 2016. Available from http://vizhub.healthdata.org/gbd-compare. Accessed 20th December 2017.
  19. 19.
    Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–57.CrossRefGoogle Scholar
  20. 20.
    Winkler AS, Dent W, Stelzhammer B, et al. Prevalence of migraine headache in a rural area of northern Tanzania: a community-based door-to-door survey. Cephalalgia. 2010;30:582–92.CrossRefGoogle Scholar
  21. 21.
    Merikangas KR, Cui L, Richardson AK, et al. Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study. BMJ. 2011;343:d5076.CrossRefGoogle Scholar
  22. 22.
    Ferrante T, Castellini P, Abrignani G, et al. The PACE study: past-year prevalence of migraine in Parma’s adult general population. Cephalalgia. 2012;32:358–65.CrossRefGoogle Scholar
  23. 23.
    Ertas M, Baykan B, Orhan EK, et al. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain. 2012;13:147–57.CrossRefGoogle Scholar
  24. 24.
    Silva Junior AA, Bigal M, Vasconcelos LP, et al. Prevalence and burden of headaches as assessed by the health family program. Headache. 2012;52:483–90.CrossRefGoogle Scholar
  25. 25.
    Russell MB, Rasmussen BK, Thorvaldsen P, et al. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995;24:612–8.CrossRefGoogle Scholar
  26. 26.
    Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30:599–609.CrossRefGoogle Scholar
  27. 27.
    Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52:1456–70.CrossRefGoogle Scholar
  28. 28.
    Katsarava Z, Dzagnidze A, Kukava M, et al. Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology. 2009;73:1796–803.CrossRefGoogle Scholar
  29. 29.
    da Silva A Jr, Costa EC, Gomes JB, et al. Chronic headache and comorbidities: a two-phase, population-based, cross-sectional study. Headache. 2010;50:1306–12.CrossRefGoogle Scholar
  30. 30.
    Lyngberg AC, Rasmussen BK, Jorgensen T, et al. Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol. 2005;161:1066–73.CrossRefGoogle Scholar
  31. 31.
    Breslau N, Davis GC, Schultz LR, et al. Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache. 1994;34:387–93.CrossRefGoogle Scholar
  32. 32.
    Breslau N, Chilcoat HD, Andreski P. Further evidence on the link between migraine and neuroticism. Neurology. 1996;47:663–7.CrossRefGoogle Scholar
  33. 33.
    Swartz KL, Pratt LA, Armenian HK, et al. Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry. 2000;57:945–50.CrossRefGoogle Scholar
  34. 34.
    Stewart WF, Linet MS, Celentano DD, et al. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991;134:1111–20.CrossRefGoogle Scholar
  35. 35.
    Stang PE, Yanagihara PA, Swanson JW, et al. Incidence of migraine headache: a population-based study in Olmsted County, Minnesota. Neurology. 1992;42:1657–62.CrossRefGoogle Scholar
  36. 36.
    Ulrich V, Gervil M, Fenger K, et al. The prevalence and characteristics of migraine in twins from the general population. Headache. 1999;39:173–80.CrossRefGoogle Scholar
  37. 37.
    Nachit-Ouinekh F, Dartigues JF, Chrysostome V, et al. Evolution of migraine after a 10-year follow-up. Headache. 2005;45:1280–7.CrossRefGoogle Scholar
  38. 38.
    Eriksen MK, Thomsen LL, Russell MB. Prognosis of migraine with aura. Cephalalgia. 2004;24:18–22.CrossRefGoogle Scholar
  39. 39.
    Cologno D, Torelli P, Manzoni GC. Migraine with aura: a review of 81 patients at 10-20 years’ follow-up. Cephalalgia. 1998;18:690–6.CrossRefGoogle Scholar
  40. 40.
    Sillanpaa M, Saarinen MM. Long term outcome of childhood onset headache: a prospective community study. Cephalalgia. 2018;38:1159.CrossRefGoogle Scholar
  41. 41.
    Ozge A, Sasmaz T, Cakmak SE, et al. Epidemiological-based childhood headache natural history study: after an interval of six years. Cephalalgia. 2010;30:703–12.CrossRefGoogle Scholar
  42. 42.
    Guidetti V, Galli F. Evolution of headache in childhood and adolescence: an 8-year follow-up. Cephalalgia. 1998;18:449–54.CrossRefGoogle Scholar
  43. 43.
    Kienbacher C, Wober C, Zesch HE, et al. Clinical features, classification and prognosis of migraine and tension-type headache in children and adolescents: a long-term follow-up study. Cephalalgia. 2006;26:820–30.CrossRefGoogle Scholar
  44. 44.
    Lyngberg AC, Rasmussen BK, Jorgensen T, et al. Prognosis of migraine and tension-type headache: a population-based follow-up study. Neurology. 2005;65:580–5.CrossRefGoogle Scholar
  45. 45.
    Henning V, Katsarava Z, Obermann M, et al. Remission of chronic headache: rates, potential predictors and the role of medication, follow-up results of the German Headache Consortium (GHC) Study. Cephalalgia. 2018;38:551.CrossRefGoogle Scholar
  46. 46.
    Scher AI, Stewart WF, Ricci JA, et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106:81–9.CrossRefGoogle Scholar
  47. 47.
    Kelman L. Pain characteristics of the acute migraine attack. Headache. 2006;46:942–53.CrossRefGoogle Scholar
  48. 48.
    Bolay H, Ozge A, Saginc P, et al. Gender influences headache characteristics with increasing age in migraine patients. Cephalalgia. 2015;35:792–800.CrossRefGoogle Scholar
  49. 49.
    Kallela M, Wessman M, Farkkila M, et al. Clinical characteristics of migraine in a population-based twin sample: similarities and differences between migraine with and without aura. Cephalalgia. 1999;19:151–8.CrossRefGoogle Scholar
  50. 50.
    Murtaza M, Kisat M, Daniel H, et al. Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data. PLoS One. 2009;4:e5827.CrossRefGoogle Scholar
  51. 51.
    Wober-Bingol C, Wober C, Karwautz A, et al. Clinical features of migraine: a cross-sectional study in patients aged three to sixty-nine. Cephalalgia. 2004;24:12–7.CrossRefGoogle Scholar
  52. 52.
    Steiner TJ, Scher AI, Stewart WF, et al. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia. 2003;23:519–27.CrossRefGoogle Scholar
  53. 53.
    Franconi F, Finocchi C, Allais G, et al. Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans. Neurol Sci. 2014;35(Suppl 1):99–105.CrossRefGoogle Scholar
  54. 54.
    Kelman L, Harper SQ, Hu X, et al. Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline. Curr Med Res Opin. 2010;26:2097–104.CrossRefGoogle Scholar
  55. 55.
    Russell MB, Rasmussen BK, Fenger K, et al. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia. 1996;16:239–45.CrossRefGoogle Scholar
  56. 56.
    Ozge A, Uluduz D, Selekler M, et al. Gender differences in older adults with chronic migraine in Turkey. Geriatr Gerontol Int. 2015;15:652–8.CrossRefGoogle Scholar
  57. 57.
    Manandhar K, Risal A, Linde M, et al. The burden of headache disorders in Nepal: estimates from a population-based survey. J Headache Pain. 2015;17:3.CrossRefGoogle Scholar
  58. 58.
    Rastenyte D, Mickeviciene D, Stovner LJ, et al. Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project. J Headache Pain. 2017;18:53.CrossRefGoogle Scholar
  59. 59.
    Vetvik KG, Benth JS, MacGregor EA, et al. Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine. Cephalalgia. 2015;35:1261–8.CrossRefGoogle Scholar
  60. 60.
    MacGregor EA, Victor TW, Hu X, et al. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache. 2010;50:528–38.CrossRefGoogle Scholar
  61. 61.
    Pinkerman B, Holroyd K. Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine. Cephalalgia. 2010;30:1187–94.CrossRefGoogle Scholar
  62. 62.
    Henry P, Auray JP, Gaudin AF, et al. Prevalence and clinical characteristics of migraine in France. Neurology. 2002;59:232–7.CrossRefGoogle Scholar
  63. 63.
    d’Agostino VC, Francia E, Licursi V, et al. Clinical and personality features of allodynic migraine. Neurol Sci. 2010;31(Suppl 1):S159–61.CrossRefGoogle Scholar
  64. 64.
    Slater S, Crawford MJ, Kabbouche MA, et al. Effects of gender and age on paediatric headache. Cephalalgia. 2009;29:969–73.CrossRefGoogle Scholar
  65. 65.
    Hansen JM, Goadsby PJ, Charles AC. Variability of clinical features in attacks of migraine with aura. Cephalalgia. 2016;36:216–24.CrossRefGoogle Scholar
  66. 66.
    Robinson ME, Riley JL III, Myers CD, et al. Gender role expectations of pain: relationship to sex differences in pain. J Pain. 2001;2:251–7.CrossRefGoogle Scholar
  67. 67.
    Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology. 1994;44:S24–39.CrossRefGoogle Scholar
  68. 68.
    Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813–8.CrossRefGoogle Scholar
  69. 69.
    Stewart WF, Lipton RB, Kolodner KB, et al. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88:41–52.CrossRefGoogle Scholar
  70. 70.
    Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia. 1996;16:231–8. discussion 15.CrossRefGoogle Scholar
  71. 71.
    Henry P, Michel P, Brochet B, et al. A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia. 1992;12:229–37. discussion 186.CrossRefGoogle Scholar
  72. 72.
    Steiner T. The HALT and HART indices. J Headache Pain. 2007;8(Suppl 1):S22–5.Google Scholar
  73. 73.
    Steiner TJ, Stovner LJ, Katsarava Z, et al. The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain. 2014;15:31.CrossRefGoogle Scholar
  74. 74.
    Rao GN, Kulkarni GB, Gururaj G, et al. The burden attributable to headache disorders in India: estimates from a community-based study in Karnataka State. J Headache Pain. 2015;16:94.CrossRefGoogle Scholar
  75. 75.
    Zebenigus M, Tekle-Haimanot R, Worku DK, et al. The burden of headache disorders in Ethiopia: national estimates from a population-based door-to-door survey. J Headache Pain. 2017;18:58.CrossRefGoogle Scholar
  76. 76.
    Akyol A, Kiylioglu N, Aydin I, et al. Epidemiology and clinical characteristics of migraine among school children in the Menderes region. Cephalalgia. 2007;27:781–7.CrossRefGoogle Scholar
  77. 77.
    Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;19:703–11.CrossRefGoogle Scholar
  78. 78.
    Messali A, Sanderson JC, Blumenfeld AM, et al. Direct and indirect costs of chronic and episodic migraine in the United States: a web-based survey. Headache. 2016;56:306–22.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of NeurologyAkershus University HospitalLørenskogNorway

Personalised recommendations